Axsome Therapeutics, Inc. (AXSM)
163.89
+0.70
(+0.43%)
USD |
NASDAQ |
Feb 27, 16:00
164.00
+0.11
(+0.07%)
After-Hours: 20:00
Axsome Therapeutics Research and Development Expense (TTM) : 182.48M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 254.91M |
| Gilead Sciences, Inc. | 5.688B |
| Vanda Pharmaceuticals, Inc. | 109.27M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Amicus Therapeutics, Inc. | 135.84M |